Literature DB >> 11102281

The risks of transfusion-transmitted infection: direct estimation and mathematical modelling.

S H Kleinman1, M P Busch.   

Abstract

Direct measurement of the risk of transfusion-transmitted infection (TTI) is practical and accurate only if the level of risk is high. Historically, studies that established frozen repositories of transfusion recipient and/or blood donor samples were important in establishing the risk of many TTI agents, including the human immunodeficiency virus (HIV), hepatitis B virus (HBV) and hepatitis C virus (HCV). However, given the current very low risk of TTI, mathematical modelling is necessary to estimate the magnitude of such a risk. For agents for which routine blood donor screening is performed, most of this risk comes from transfusion of units collected in the window period between donor infection and a positive blood screening assay. The incidence/window period model has been used to estimate the magnitude of such risks (of the order of 1:100 000 to 1:1 000 000) and for predicting the extent of risk reduction that can be expected with implementation of new tests. Direct estimation and mathematical modelling approaches are both important tools for future assessment of potential, new or emerging TTI agents. Copyright 2000 Harcourt Publishers Ltd.

Entities:  

Mesh:

Year:  2000        PMID: 11102281     DOI: 10.1053/beha.2000.0104

Source DB:  PubMed          Journal:  Baillieres Best Pract Res Clin Haematol


  8 in total

1.  Safety in transfusion medicine.

Authors:  Giuseppe Aprili
Journal:  Blood Transfus       Date:  2008-07       Impact factor: 3.443

2.  Significant closure of the human immunodeficiency virus type 1 and hepatitis C virus preseroconversion detection windows with a transcription-mediated-amplification-driven assay.

Authors:  Daniel P Kolk; Janel Dockter; Jeff Linnen; Marcy Ho-Sing-Loy; Kristin Gillotte-Taylor; Sherrol H McDonough; Larry Mimms; Cristina Giachetti
Journal:  J Clin Microbiol       Date:  2002-05       Impact factor: 5.948

3.  Incidence and estimated rates of residual risk for HIV, hepatitis C, hepatitis B and human T-cell lymphotropic viruses in blood donors in Canada, 1990-2000.

Authors:  Jo Anne Chiavetta; Michael Escobar; Alice Newman; Yaohua He; Pete Driezen; Shelley Deeks; Devon E Hone; Sheila F O'Brien; Graham Sher
Journal:  CMAJ       Date:  2003-10-14       Impact factor: 8.262

4.  Reducing the risk of hepatitis B virus transfusion-transmitted infection.

Authors:  Christoph Niederhauser
Journal:  J Blood Med       Date:  2011-07-18

5.  The importance of hemovigilance in the transmission of infectious diseases.

Authors:  Paulo Roberto Juliano Martins; Raquel Alves Martins; Valdirene de Fátima Barbosa; Gilberto de Araujo Pereira; Hélio Moraes-Souza; Sheila Soares Silva
Journal:  Rev Bras Hematol Hemoter       Date:  2013

6.  Global Mortality Burden of Cirrhosis and Liver Cancer Attributable to Injection Drug Use, 1990-2016: An Age-Period-Cohort and Spatial Autocorrelation Analysis.

Authors:  Jin Yang; Yunquan Zhang; Lisha Luo; Runtang Meng; Chuanhua Yu
Journal:  Int J Environ Res Public Health       Date:  2018-01-22       Impact factor: 3.390

7.  Effects of Red Blood Cell Transfusions on Distant Metastases of Oral Squamous Cell Carcinomas.

Authors:  Leonard Simon Brandenburg; Marc Christian Metzger; Philipp Poxleitner; Pit Jacob Voss; Kirstin Vach; Johannes Hell; Konstantin Hasel; Julia Vera Weingart; Steffen Jochen Schwarz; Michael Andreas Ermer
Journal:  Cancers (Basel)       Date:  2021-12-28       Impact factor: 6.639

Review 8.  Seroprevalence of hepatitis B and C in Nepal: a systematic review (1973-2017).

Authors:  Marcelo Contardo Moscoso Naveira; Komal Badal; Jagadish Dhakal; Neichu Angami Mayer; Bina Pokharel; Ruben Frank Del Prado
Journal:  Hepatol Med Policy       Date:  2018-09-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.